Wednesday, September 17, 2014 1:47:33 AM
If you are an investor in Nuvilex you need to ask yourself these important questions...
1. Do you agree with how Nuvilex is handling their cash,issuance of shares, management?
- They are compensating themselves this year alone over $14,000,000+ in shareholder money. This causes the stock to drop frequently due to the extremely low price/share?
- Nuvilex is currently over 700,000,000+ outstanding shares
-Millions of unregistered shares.
-In 2014 loss of $5,000,000+ due to stock conversion
- At least 4 individuals affiliated directly to Nuvilex have been in somewhat investigated by the feds, sec, sba, been sued, class action.
- Tim Matula used to be on the Topaz Group Board of Directors and Tresurer and also was a Director At VelaTel
TIM MATULA IS NAMED IN A LAWSUIT FOR VIOLATING FEDERAL SECURITIES LAWS
From the lawsuit
link here - http://securities.stanford.edu/filings-documents/1029/TPZ03-01/20031218_f01c_033929.pdf
Currently Compensating himself $3,000,000+ @ Nuvilex
President of Medical Marijuana Sciences
- Kenneth Waggoner CEO
- VP @ VelaTel (once ChinaTel, was found to be a sham)
These two have been tied to VelaTel
Another connection is Chardan Capital...
Chardan has recently become LIVE's (Tim Matulas other company who he's on the board of) Sales Agent for a fee...
http://www.businesswire.com/news/home/20140522005559/en/LiveDeal-Comments-ATM-Offering#.VAT7APnIWCk
Sound Familiar?
Chardan's CEO Kerry Propper has been under federal investigation as well as his father...
From the link (http://pibillwarner.wordpress.com/2010/03/30/david-j-stern-law-office-is-djsp-enterprises-on-nasdaq-major-shareholders-david-j-stern-and-kerry-s-propper-the-subject-of-department-of-justice-investigation-and-sba-law-suit/)
Recent PMCB News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 10:06:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/21/2023 09:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/18/2023 10:04:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 09:00:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2023 01:56:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:28 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/04/2023 08:40:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:01:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/31/2023 09:18:17 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM